Marvel Biosciences Corp (MRVL) — Tangible Net Worth Ratio
Marvel Biosciences Corp (MRVL) has a Tangible Net Worth Ratio of 100.0% as of January 2023. This metric is calculated by deducting intangible assets (CA$0.00) from net assets (CA$14.91K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Marvel Biosciences Corp (MRVL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Marvel Biosciences Corp Tangible Net Worth Ratio (2020–2022)
This chart shows how Marvel Biosciences Corp's Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2022. As of January 2023, the ratio stands at 100.0%, reflecting net assets of CA$14.91K with intangible assets of CA$0.00 CAD. See how many days can Marvel Biosciences Corp fund operations to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Marvel Biosciences Corp (2020–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Marvel Biosciences Corp from 2020 to 2022, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Marvel Biosciences Corp market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CAD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | CA$195.54K | CA$0.00 | CA$913.54K | ▲ +0.0 pp |
| 2021 | 100.0% | CA$2.36 Million | CA$0.00 | CA$2.47 Million | ▲ +0.0 pp |
| 2020 | 100.0% | CA$118.80K | CA$0.00 | CA$295.99K | — |